[1]
M. B. Chopda, S. G. Gadkar, Y. A. Lakshmaiah, R. K. Lambata, D. C. Dabhade, and S. R. Newale, “Nationwide surveillance for Telmisartan alone or with combination at real world therapy in Indian patients with hypertension (START)”, Int J Res Med Sci, vol. 9, no. 10, pp. 3091–3094, Sep. 2021.